SCHEMBL903926

SCHEMBL903926

CCc1cnc(N2CC3[C@@H](COc4ccc(-c5ccc(C#N)cc5)nc4)[C@@H]3C2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.47
CYP11B1 P15538 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
KDM1A O60341 2/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
HRH3 Q9Y5N1 5/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903901 0.93 HDAC3 (0.41) GPR119KDM1AHDAC3HDAC4HDAC1
SCHEMBL10068058 0.86 GPR119 (0.47) GPR119CYP11B1L3MBTL1MAPTRAB9A
SCHEMBL904019 0.84 GPR119 (0.46) GPR119CYP11B1L3MBTL1MAPTRAB9A
SCHEMBL10067420 0.83 GPR119 (0.47) GPR119
SCHEMBL10067703 0.82 GPR119 (0.45) GPR119CYP11B1KDM4EALDH1A1RAB9A
SCHEMBL10067704 0.82 GPR119 (0.45) GPR119CYP11B1KDM4EALDH1A1RAB9A
SCHEMBL904014 0.80 HRH3 (0.45) GPR119KDM1AHDAC3HDAC4HDAC1
SCHEMBL903982 0.77 GPR119 (0.47) GPR119HDAC3HDAC4HDAC1HDAC7
SCHEMBL904171 0.76 GPR119 (0.41) GPR119CYP11B1
SCHEMBL904204 0.76 GPR119 (0.52) GPR119KDM1AHRH3HRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed